• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Pediatric Infect Dis Soc . Risk of Highly Pathogenic Avian Influenza A/H5N1 Virus in Pediatrics

tetano

Editor, Senior Moderator
J Pediatric Infect Dis Soc


. 2025 Apr 28:piaf035.
doi: 10.1093/jpids/piaf035. Online ahead of print. Risk of Highly Pathogenic Avian Influenza A/H5N1 Virus in Pediatrics

C Mary Healy[SUP] 1 [/SUP]



Affiliations
Abstract

Highly Pathogenic Avian Influenza A/H5N1 Virus has been found in multiple US states since 2024. While human infection risk is currently low, children are a high-risk group for severe infection as the virus evolves. Preventive efforts should prioritize children in vaccine and therapeutic clinical trials and vaccine implementation strategies.

Keywords: Avian Influenza; Clinical trials; Pandemic; Pediatric; Vaccine.

 
Back
Top Bottom